The maker of a new class of weight loss drug has announced its upping its 2024 profit forecasts as the popularity of their medications surges in the US.
Danish firm Novo Nordisk, which makes Ozempic and Wegovy, says it's also racing to boost output to meet demand.
Trent Murray reports from Berlin.
Danish firm Novo Nordisk, which makes Ozempic and Wegovy, says it's also racing to boost output to meet demand.
Trent Murray reports from Berlin.
OUT: SOC
TIME: 39 seconds